Greg Deener

Company: iCell Gene Therapeutics

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Optimizing Patient Treatment Procedure for Best Outcomes 2:00 pm

• Discussing regiments for patients such as ideal dosing, timing of certain procedures, and sample collection methods • Evaluating the need for conditioning regiments such as lymphodepletion • How long do patients need to be hospitalized?Read more

day: Day Two Track B, PM

Long Term Follow-up of BCMA CD19 cCAR Therapy in Lupus 1:30 pm

• A complete humoral reset delivers long-term, medication-free complete remission • Will present 2-5 year follow up in 12 lupus patients NEW DATARead more

day: Day Two Track B, PM

Workshop A 9:00 am

Owing to exciting advancements in the applications of cell therapies to autoimmune diseases developers are looking to grasp as many opportunities here as possible. However, with the vast amount of autoimmune indications, numerous cell therapy types, and other available therapy modalities, assessing which patients would benefit most from cell therapies and the feasibility of entering…Read more

day: Pre-Conference Workshop Day